Bionoid Pharma Stock Price Prediction
| BINP Stock | USD 0.20 0.05 33.33% |
Oversold Vs Overbought
21
Oversold | Overbought |
Using Bionoid Pharma hype-based prediction, you can estimate the value of Bionoid Pharma from the perspective of Bionoid Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bionoid Pharma to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Bionoid because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bionoid Pharma after-hype prediction price | USD 0.2 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bionoid |
Bionoid Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Bionoid Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bionoid Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Bionoid Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bionoid Pharma Estimiated After-Hype Price Volatility
In the context of predicting Bionoid Pharma's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bionoid Pharma's historical news coverage. Bionoid Pharma's after-hype downside and upside margins for the prediction period are 0.01 and 13.59, respectively. We have considered Bionoid Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bionoid Pharma is out of control at this time. Analysis and calculation of next after-hype price of Bionoid Pharma is based on 3 months time horizon.
Bionoid Pharma Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Bionoid Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bionoid Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bionoid Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.43 | 13.39 | 0.00 | 0.03 | 0 Events / Month | 3 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.20 | 0.20 | 0.00 |
|
Bionoid Pharma Hype Timeline
Bionoid Pharma is currently traded for 0.20. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.03. Bionoid is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 0.43%. %. The volatility of related hype on Bionoid Pharma is about 22316.67%, with the expected price after the next announcement by competition of 0.23. The company recorded a loss per share of 46.27. Bionoid Pharma had not issued any dividends in recent years. The entity had 1:2500 split on the 25th of February 2020. Given the investment horizon of 90 days the next estimated press release will be in 5 to 10 days. Check out Bionoid Pharma Basic Forecasting Models to cross-verify your projections.Bionoid Pharma Related Hype Analysis
Having access to credible news sources related to Bionoid Pharma's direct competition is more important than ever and may enhance your ability to predict Bionoid Pharma's future price movements. Getting to know how Bionoid Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bionoid Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AFML | Aerofoam Metals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ZIJMF | Zijin Mining Group | 0.00 | 0 per month | 2.73 | (0.01) | 5.58 | (5.24) | 21.80 | |
| BRID | Bridgford Foods | (0.11) | 7 per month | 0.00 | (0.1) | 4.52 | (7.02) | 32.90 | |
| HFFG | Hf Foods Group | (0.17) | 5 per month | 3.41 | 0.03 | 6.34 | (5.23) | 23.09 | |
| TBBB | BBB Foods | 0.81 | 11 per month | 2.09 | 0.04 | 3.20 | (3.51) | 15.41 | |
| SUM | Summit Materials | (0.05) | 9 per month | 1.74 | 0.13 | 4.18 | (2.73) | 9.88 | |
| PMNXF | Perseus Mining Limited | 0.00 | 0 per month | 3.45 | (0.03) | 6.32 | (5.71) | 20.57 | |
| CAHPF | Evolution Mining | 0.00 | 0 per month | 2.75 | 0.06 | 5.39 | (5.43) | 21.17 |
Bionoid Pharma Additional Predictive Modules
Most predictive techniques to examine Bionoid price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bionoid using various technical indicators. When you analyze Bionoid charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bionoid Pharma Predictive Indicators
The successful prediction of Bionoid Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bionoid Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bionoid Pharma based on analysis of Bionoid Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bionoid Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bionoid Pharma's related companies.
Story Coverage note for Bionoid Pharma
The number of cover stories for Bionoid Pharma depends on current market conditions and Bionoid Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bionoid Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bionoid Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Bionoid Pink Sheet Analysis
When running Bionoid Pharma's price analysis, check to measure Bionoid Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionoid Pharma is operating at the current time. Most of Bionoid Pharma's value examination focuses on studying past and present price action to predict the probability of Bionoid Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionoid Pharma's price. Additionally, you may evaluate how the addition of Bionoid Pharma to your portfolios can decrease your overall portfolio volatility.